Marianne De Backer, CEO, Vir Biotechnology, discusses her three decades of experience in the pharmaceutical industry and her passion for making a difference for patients as a biotech CEO.
Sabrina Johnson, President & CEO, Daré Bioscience, a trailblazer in women's healthcare, discusses her committment to advancing improvements in that field.
Eric Dube, CEO, Travere Therapeutics discusses leading a team through change, innovation, and the challenges of bringing therapeutics to patients while the rules are still being written.
Ted Love, Chairman, Biotechnology Industry Organization (BIO), discusses building a company to address an unmet need.
A candid discussion with Lou Lange, Partner, Asset Management Ventures & Former CEO, CV Therapeutics about building and maintaining lasting relationships.
A candid discussion with Athena Countouriotis, President & CEO of Turning Point Therapeutics.
Stephen Aselage, CEO of Retrophin, Inc. discusses how his team recovered and rebuilt the company after ousting Martin Shkreli as CEO.
A candid discussion of the lessons learned during the journey through the evolution of the biotech industry and successive leadership positions with Paul J. Hastings, President and CEO, Nkarta Therapeutics, Inc and former CEO of OncoMed Pharmaceuticals.
A candid discussion with Edwin Moses, PhD, CEO of Ablynx NV.
An interview with Rich Heyman, PhD, Executive Chairman & Co-Founder, Metacrine Inc.; former CEO of Seragon & Aragon.
A candid discussion with four European Biotech CEOs: Geoff McDonough, CEO of Generation Bio; Simon Moroney, CEO & Co-Founder, MorphoSys AG; Edwin Moses, PhD, CEO of Ablynx NV; and Denise Scots-Knight, CEO & Co-Founder, Mereo BioPharma Group plc.
A candid discussion of the lessons learned during the journey through the evolution of the biotech industry and successive leadership positions with Paul J. Hastings, President and CEO, Nkarta Therapeutics, Inc and former CEO of OncoMed Pharmaceuticals.
